Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $80.00$65.00 | $6.50/mg | In stock | Jul 9 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| OS-2026-9837 | Jun 2026 | 97.0% | Janoshik Analytical | — | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. TB-500 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Optima Supply sell TB-500?
Yes — Optima Supply currently lists TB-500 in 1 variant starting at $65.00 ($6.50/mg).
Is Optima Supply's TB-500 third-party tested?
Yes — Disclosed Labs has indexed 6 Certificates of Analysis for Optima Supply's TB-500, with the most recent showing 97.0% purity. Optima Supply holds an overall trust grade of B (80/100) across all 131 COAs on file.
What is Optima Supply's trust grade for TB-500?
Optima Supply has an overall Disclosed Labs trust grade of B (80/100), computed from 131 COAs across all peptides. The most recent TB-500 COA was issued by Janoshik Analytical.
Where is the cheapest TB-500?
As of the latest data, Peptide Supply Co. offers TB-500 at $3.40/mg — compare with Optima Supply's listing at $6.50/mg. See the full TB-500 price comparison.
Is TB-500 legal to buy?
TB-500 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| OS-2026-9422 | Jun 2026 | 98.3% | Janoshik Analytical | — | Confirmed | View |
| — | Dec 2025 | — | Janoshik Analytical | — | Confirmed | View |
| — | Nov 2025 | 99.3% | Janoshik Analytical | — | Confirmed | View |
| TB500-6053 | Aug 2024 | — | Janoshik Analytical | Heavy metals | Confirmed | View |
| TB1003 | Jul 2024 | — | Janoshik Analytical | Endotoxin | Confirmed | View |